Related Experiment Videos
Beta-adrenergic receptor blockade suppresses glial scar formation
1Department of Anatomy and Cell Biology, Emory University School of Medicine, Atlanta, Georgia 30322.
Experimental Neurology
|April 1, 1993
Summary
Beta-blockers, such as L-propranolol, significantly reduce astrocyte hypertrophy and glial scar formation in injured spinal cords by blocking beta-adrenergic receptors. This finding suggests a potential therapeutic target for neurological injuries.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Isoproterenol stimulates astrocyte process formation in vitro.
- Beta-adrenergic receptors are present in adult rat brain astrocytes.
- Blood-borne macrophages with beta-adrenergic receptors influence glial cells.
Purpose of the Study:
- To test if beta-antagonists prevent astrocyte hypertrophy in injured spinal cords.
- To investigate the role of beta-adrenergic receptors in glial scar formation.
Main Methods:
- Induced glial scar indirectly via sciatic nerve ricin injection, avoiding physical trauma.
- Assessed astrocyte hypertrophy using glial fibrillary acidic protein (GFAP) immunocytochemistry and optical density.
- Administered L-propranolol via osmotic pump and measured beta-adrenergic receptor density using [125I]iodocyanopindolol autoradiography.
Main Results:
- Ricin treatment increased GFAP by 11.8% (P < 0.0001), indicating astrocyte hypertrophy.
- L-propranolol infusion reduced GFAP increase to 3.2% (P < 0.001), a 73% reduction in hypertrophy.
- Beta-adrenergic receptor density increased by 26% on the gliotic side and only 3.5% after propranolol treatment.
Conclusions:
- Beta-adrenergic receptor blockade with L-propranolol effectively reduces astrocyte hypertrophy and glial scar formation.
- This suggests beta-adrenergic signaling plays a key role in reactive astrogliosis following spinal cord injury.
- Targeting beta-adrenergic receptors may offer a therapeutic strategy for managing spinal cord injury-induced glial scarring.